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Background: The annual number of international tourist arrivals has recently exceeded one billion, yet surprisingly
few studies have characterized travelers’ behavior, illness, and risk factors in a prospective setting. Particularly scarce
are surveys of data spanning travel, return, and follow-up of the same cohort.
This study examines behavior and illness among travelers while abroad, after return home, and at follow-up.
Patterns of behavior connected to type of travel and illness are characterized so as to identify risk factors and
provide background data for pre-travel advice.
Methods: Volunteers to this prospective cohort study were recruited at visits to a travel clinic prior to departure.
Data on the subjects’ health and behavior were collected by questionnaires before and after journeys and over a
three-week follow-up. In addition, the subjects were asked to fill in health diaries while traveling.
Results: The final study population consisted of 460 subjects, 79 % of whom reported illness during travel or on
arrival: 69 % had travelers’ diarrhea (TD), 17 % skin problems, 17 % fever, 12 % vomiting, 8 % respiratory tract
infection, 4 % urinary tract infection, 2 % ear infection, 4 % gastrointestinal complaints other than TD or vomiting,
and 4 % other symptoms. Of all subjects, 10 % consulted a doctor and 0.7 % were hospitalized; 18 % took
antimicrobials, with TD as the most common indication (64 %). Ongoing symptoms were reported by 25 % of all
travelers upon return home.
During the three-week follow-up (return rate 51 %), 32 % of respondents developed new-onset symptoms, 20 %
visited a doctor and 1.7 % were hospitalized.
Factors predisposing to health problems were identified by multivariable analysis: certain regions (Southern Asia,
South-Eastern Asia, and Eastern Africa), female gender, young age, and long travel duration.
Conclusions: Despite proper preventive measures like vaccinations, malaria prophylaxis, and travel advice, the
majority of our subjects fell ill during or after travel. As the symptoms mostly remained mild, health care services
were seldom needed. Typical traveler profiles were identified, thereby providing a tool for pre-travel advice. The
finding that one third reported new-onset illness during follow-up attests to the importance of advising clients on
potential post-travel health problems already during pre-travel visits.
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According to travel records for 2015, the number of
international tourist arrivals exceeded one billion, and
half a billion people headed to emerging economies [1].
Less than half of the visitors to poor regions have been
shown to seek pre-travel health advice, as exemplified by
only 15 % of Canadians visiting hepatitis A endemic
countries [2] and 31 % of Australasians traveling to Asia,
Africa, or South America [3]. This is surprising, consid-
ering the high morbidity rates (64–70 %) reported for
visitors to developing regions [4, 5].
Investigations addressing travelers’ health have gener-
ally been retrospective and/or conducted among those
seeking medical care after their journeys [6–21]. Not
many prospective studies focus on the spectrum of trav-
elers’ diseases [4, 5, 22–27]. Among these we found only
one that looks at the same cohort during and after travel
and also includes a post-travel follow-up [4]. The princi-
pal findings of the prospective studies are mildness of
symptoms [4, 22] and small proportion of those falling
ill who seek medical care: 2–33 % of the total studyFig. 1 Study protocol, population, and information collected by questionnpopulation visit a physician and 0.1–4 % are hospital-
ized [4, 5, 22, 24, 25, 27] during travel. After return-
ing home, 9–20 % of all travelers have been reported
to see a doctor [4, 5, 22, 25] and 0.0–1.0 % to be
hospitalized [4, 22, 27]. Even though those with the
most severe symptoms probably seek medical care, it
should be noted that they represent only the tip of
the iceberg among travelers falling ill. To get a com-
prehensive view of travel-associated health problems,
prospective study designs should be employed for col-
lecting data on illness while abroad, after return, and
at follow-up.
To examine the health problems of travelers overseas,
we recently conducted a nation-wide study of a large
Finnish database provided by an assistance organization
[21]. While these data presumably cover cases with the
most severe symptoms, we sought to complete them
with a prospective study that would comprise even mild
illness. By including a post-travel follow-up, we extended
the research to symptoms not developing until after
return.aires of a total of 524 travelers recruited at the pre-travel consultation
Table 1 Demographics, travel information, and destinations of
460 travelers recruited at the travel clinic during their pre-travel
visit, all staying outside the Nordic countries for more than four
days and less than 6 months. The data are given as numbers of
cases and their proportions
Number (%a)
Sex (missing data = 0)
Male 173 (38)
Female 287 (62)
Age, median (IQR) (missing data = 0) 35 (27.0–54.0)
0–17, children 35 (8)
18–35, young adults 196 (43)
36–55, middle aged 120 (26)
56–, older travelers 109 (24)
Underlying diseases (missing data = 0) 192 (42)
Asthma, atopy and/or allergy 56 (12)
Hypertension 51 (11)
Psychiatric disorder or medication 25 (5)
Cardiovascular disease 14 (3)
GI disorder b 13 (3)
Neurological disorder 12 (3)
DM 9 (2)
Rheumatic disease 6 (1)
Other disease and conditions 78 (17)
Contraceptives or postmenopausal hormone
replacement therapy
53 (12)
Duration of travel, median in days (IQR)
(missing data = 2)
16 (12.8–27.3)
1 week or less (missing data = 0) 27 (6)
More than a week and less than a month 334 (73)
1–5 months 99 (22)
Purpose of travel (missing data = 1)
Vacation 383 (83)
Business 38 (8)
Other/multiple c 38 (8)
Geographic region (missing data = 0) d
South-Eastern Asia 107 (23)
Eastern Africa 96 (21)
Western Africa, Middle Africa 86 (19)
Southern Asia 68 (15)
Latin America and the Caribbean 41 (9)
Southern Africa 26 (6)
Europe, Northern America 15 (3)
Table 1 Demographics, travel information, and destinations of
460 travelers recruited at the travel clinic during their pre-travel
visit, all staying outside the Nordic countries for more than four
days and less than 6 months. The data are given as numbers of
cases and their proportions (Continued)
Northern Africa, Western Asia 12 (3)
Eastern Asia, Central Asia 9 (2)
a Proportion of positive among those from whom information was available
b Crohn's disease, irritable bowel syndrome, primary biliary cirrhosis,
diverticulosis, microscopic colitis, celiac disease
c 14 (3 %) travelers reported two or more purposes of travel
d Given according to primary destination. Categorized into three subgroups:
Asia (Western Asia, South-Eastern Asia, Southern Asia, Eastern Asia, and Central
Asia), Africa (Eastern Africa, Western Africa, Middle Africa, Southern Africa, and
Northern Africa), and the others (Latin America and the Caribbean, Europe,
North America)
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Volunteers and study design
Volunteers to this prospective study cohort were en-
rolled at the Travel Clinic of Aava Medical Centre
among travelers planning a journey outside the Nordic
countries for a minimum of four days and a maximum
of six months (Fig. 1). The only exclusion criterion was
non-compliance in returning questionnaires. The sub-
jects were recruited among consecutive clients at pre-
travel appointments between December 2008 and
February 2010. At the initial visit, they filled out a pre-
travel questionnaire (Q1), on return home a post-travel
questionnaire (Q2), and about three weeks later a
follow-up questionnaire (Q3). Those who failed to return
both Q1 and Q2 were excluded. In addition to the ques-
tionnaires, the subjects were asked to complete a struc-
tured diary on a voluntary basis. All volunteers were
given pre-travel advice by a health care professional.
We have earlier reported risk factors for acquiring re-
sistant intestinal microbes in the same population [28],
and, data on diarrheal pathogens, first in our methodo-
logical investigation [29] and, recently, in an etiological
study [30].
Questionnaires
The questionnaires consisted of 134 multiple-choice or
open-ended questions: Q1 comprised 47, Q2 60, and Q3
27 questions. These questionnaires were modified from
a set of survey questions routinely used for more than
10 years for ill travelers admitted to the Clinic of Infec-
tious Diseases at HUCH. All items covered are listed in
Fig. 1. The structured diary contained more specific
questions on duration and severity of symptoms, and
use of antibiotics.
Definitions
Subjects were classified as ill if they reported symptoms
implying health problems which could be travel-related.
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passage of 3 or more loose or liquid stools per day, or
more frequently than is normal for the individual
(World Health Organization [31]). At follow-up, symp-
toms which had set in more than two days after a jour-
ney and could be travel-related were categorized as
newly onset.
Destinations
The countries visited were grouped into nine geo-
graphic regions (UN categorization, modified [32]):
Southern Asia, South-Eastern Asia, Eastern Asia and
Central Asia, Southern Africa, Eastern Africa, Western
Africa and Middle Africa, Northern Africa and Western
Asia, Latin America and the Caribbean, and Europe
and Northern America (Table 1). The destination with
the greatest health risk was considered primary for
subjects traveling to several places. Here we used a
rating based on the risk map drawn up by Inter-
national SOS (Additional file 1: Figure S1 HealthMap
2010) which takes into account a range of factors: the
standard of local medical and dental care, access to
prescription drugs, the possible prevalence of serious
infectious diseases, and known cultural, linguistic and
administrative barriers.
Statistics
Univariable, bivariable and multivariable models were
used. The p-value of Pearson Chi-square tests and
Fisher’s exact test < 0.05 was considered statistically sig-
nificant. If bivariable p-value was less than 0.10, theTable 2 Numbers and proportions of travelers (n = 460) vaccinated
are given as numbers and percentages of those vaccinated or consi
Protected before
consultation, N (%a)
Vaccinated a
consultation,
Tetanus (missing data = 4) 353 (77) 96 (21)
MMR (missing data = 43) 393 (94) 21 (5)
Hepatitis A (missing data = 3) 325 (71) 130 (28)
Hepatitis B (missing data = 4) 178 (39) 124 (27)
Yellow Fever (missing data = 2) 112 (24) 153 (33)
Polio (missing data = 4) b 140 (31) 84 (18)
Typhoid fever (missing data =
3)
38 (8) 63 (14)
oral 16 (4) 59 (13)
injected 22 (5) 4 (1)
Japanese encephalitis (missing
data = 3) c
15 (3) 30 (7)
Other (missing data = 3) d 14 (3) 58 (13)
aProportion of positive among those from whom information was available
bPart of the volunteers may have chosen to skip polio vaccination during appointm
are vaccinated free of charge since polio is included in the Finnish national immun
cDespite advice many declined prophylaxis because of high price
dIncludes cholera, meningococcal, and rabies vaccinationsfactor was chosen to the multivariable logistic regression
model, and its adjusted odds ratios and 95 % confidence
intervals were calculated. Missing data were assumed to
be missing at random (MAR) and missing values were
imputed using multiple imputations in SPSS. The sta-
tistical analyzes were carried out with SPSS Statistics
(version 22.0.0.2, IBM Corp., USA).
Results
Cohort population and prophylactic measures
Of the 524 initially recruited travelers, 88 % completed
both pre- and post-travel questionnaires. The final study
population thus consisted of 460 volunteers (Fig. 1,
Table 1). A total of 233 (51 %) returned follow-up ques-
tionnaires and 295 (64 %) filled in diaries. An underlying
disease or condition was recorded for 192 (42 %)(Table 1),
more frequently among the oldest subjects (56– years,
73 %; p < 0.001), and females (45 %; p = 0.046) than in
other age groups (0–55 years, 23–38 %) or among males
(36 %). Data on vaccinations are presented in Table 2
and on antimalarials in Table 3.
Travel information and behavior
The 460 travelers visited 77 countries altogether (UN
definition); India (64), Thailand (60), Gambia (50),
Tanzania (48), and Kenya (40) ranking as their most popu-
lar destinations. Overall 662 country visits were made
(average 1.45 per person; range 1–8). The 30 most favored
countries accounted for 560 journeys (85 %); only three
destinations were in developed regions (UN definition
[33]): USA (8), Spain (7), and the Netherlands (5).before the travel clinic appointment or at consultation. The data
dered protected according to Finnish recommendations
t
N (%a)
Protected according to recommendations given for the
region visited, N (%a)
449 (98)
414 (99)
440 (100)
72 (73)
182 (96)
104 (63)
47 (65)
18 (53)
ent at the travel clinic and, instead, get it from their health center where they
ization program
Table 3 Medications taken by 460 Finnish travelers during the
trip. The medications are categorized according to indication.
The data are presented as numbers and percentages of
travelers
Number (%a)
Prophylactic antimalarial use among those
recommended (missing data = 6)
289 (98)
Atovaquone and proguanil 135 (30)
Mefloquine 70 (15)
Doxycycline 55 (12)
Chloroquine 25 (6)
Other / not known 2 (0)
Changed drug b 2 (0)
Failure in use c 7 (2)
Antimicrobials (other than doxicycline) (missing data = 0) d 81 (18)
Fluoroquinolone 53 (12)
Macrolide 9 (2)
Nitroimidazole (metronidazole or tinidatzole) 7 (2)
Amoxicillin 5 (1)
Tetracycline 1 (0)
Other / not known 25 (5)
Two or more antimicrobials (without doxycycline) 15 (3)
Treatment for malaria (missing data = 0) e 4 (1)
Gastrointestinal medication (missing data = 0) 127 (28)
Loperamide 115 (25)
Medicinal charcoal 7 (2)
Other (laxative, spasmolyte, co-phenotrope) 10 (2)
Two or more gastrointestinal medications 5 (1)
Analgesic (missing data = 0) 123 (27)
NSAID 67 (15)
Paracetamol 59 (13)
Other / not known 16 (3)
Two or more analgesics 18 (4)
Antiemetic (missing data = 0) 4 (1)
PPI or antacid (missing data = 4) 36 (8)
PPI 26 (6)
Antacid (salts/H2) 10 (2)
Probiotics and prebiotics (missing data = 3) f 270 (59)
Starting before travel 11 (2)
Using only during travel 123 (27)
Starting before and using during travel 136 (30)
a Total use of all travelers among those from whom information was available
b Each of these changed the medication from doxycycline to mefloquine
c Did not use as recommended (2 did not take at all, 1 stopped because of
adverse effects, 4 used irregularly): atovaquone/proguanil (4), doxycycline (2),
mefloquine (1); 10 had prescription but did not enter malaria area; 33 traveled
to endemic countries yet visited only low prevalence areas
d 52 (11 % of all) used antimicrobials for TD
e All in Africa, three of four were tested; two negative, one positive
f If only product mentioned, presumed to be used while traveling
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quently by young adults (18–35 years, 17 %) and the
middle-aged (36–55 years, 13 %) than children (0–17
years, 6 %) and older travelers (56– years, 6 %) (p =
0.016). Young adults proved more likely than the others
to have freshwater contact, neglect hand washing, and
not to shun salads or eating without utensils. Men con-
sumed more alcohol than women (p < 0.001).
Traveler profiles
Traveler profiles by age
The median duration of travel was 23 days for the young
adults and 15 days for others (age group vs travel dur-
ation group p < 0.001). Young adults and children stayed
most often in guest houses, while the others preferred
hotel accommodation (Table 4).
Traveler profiles by destinations
To obtain data on typical travelers to the two most pre-
ferred geographic regions, Africa and Asia, the destina-
tions were categorized into three subgroups: Africa (n =
212), Asia (n = 192), and others (n = 56). Their character-
istics are presented in Table 4. In bivariable analysis, dis-
tribution of age and duration of journey differed
between those heading for Africa and those favoring
Asia. The median age was higher for those visiting
Africa, and the journey was shorter. Likewise, compared
to Asia, visitors to Africa had less frequent freshwater
contact and ate uncooked meat/fish less often.
Illness
Factors with p < 0.1 in the bivariable analyses (Table 5)
were included in the multivariable analyses (Table 6).
Destination associated strongly with health problems.
Females were more predisposed to falling ill. Overall, the
risk was greatest at 31.5 years of age. The longer the
travel, the greater the risk of contracting an illness – it
increased each day by 2.5 %. Eating raw meat/fish was
associated with healthier travelers.
Geographic regions with demographics and propor-
tions of sick travelers are presented in Fig. 2. Illness rates
by geographic regions were found to accord with re-
spective risk ratings by International SOS (Additional
file 2: Figure S2).
Health care was sought by 10 % of all subjects and by
13 % of those fallen ill during travel; 10 % and 13 % vis-
ited a physician and 0.7 % and 0.9 %, respectively, were
hospitalized (Table 7). The most common reason for
consulting health care professionals while abroad was
TD – 4 % of all travelers visited a doctor, and 0.4 % were
subsequently admitted to hospital because of this illness.
During follow-up, about one-third reported new-onset
health problems (Table 7). Their most common single
Table 4 Traveler profiles presented by demographics (destination, sex, age, duration of travel, purpose of travel) with travel behavior in bivariable analysis for 460 travelers.
Results are given in percentages with the largest group shown in bold
Number
(%)
Destination % Sex % Age group (years) % Duration of travel (days) % Purpose of travel %
Africa Asia other p-value male female p-value 0–
17
18–
35
36–
55
56– p-value 1–7 8–
29
30–
160
p-value vacation business other p-value
Age group
(missing data = 0)
<0.001* 0.833 <0.001* 0.056
0–17 35 (8) 8 7 11 8 7 30 7 3 9 0 3
18–35 196 (43) 32 55 41 43 42 22 36 72 42 37 61
36–55 120 (26) 30 23 23 27 25 33 29 13 26 39 16
56– 109 (24) 31 15 25 21 25 15 28 12 24 24 21
Duration of travel, days
(missing data = 0)
<0.001* 0.473 <0.001* <0.001d*
1–7 27 (6) 2 6 20 7 5 23 3 8 4 6 13 0
8–29 334 (73) 81 63 73 72 73 69 61 82 85 79 53 29
30–160 99 (22) 17 31 7 20 22 9 36 11 11 15 34 71
Purpose of travel
(missing data = 1) a
0.034d* 0.002* 0.056 <0.001d*
vacation 383 (84) 78 88 91 86 82 97 81 83 84 81 91 60
business 37 (8) 12 5 4 11 7 0 7 13 8 19 6 13
other/multiple 35 (8) 10 7 5 3 11 3 12 5 7 0 3 27
Accommodation
(missing data = 11) b
<0.001* 0.008* <0.001* <0.001* <0.001*
hotel 188 (42) 39 40 61 46 40 34 31 50 55 85 46 15 44 45 18
home of a local 71 (16) 23 9 14 9 20 26 16 11 17 15 12 29 12 16 50
guest house 190 (42) 39 52 25 45 41 40 53 39 28 0 42 56 44 39 32
Location
(missing data = 22) b
<0.001* 0.083 0.088 <0.001* 0.494
city 143 (33) 24 34 57 28 36 44 27 36 38 88 31 23 33 38 25
countryside/jungle 295 (67) 76 66 43 72 64 56 73 66 62 12 69 77 67 62 75
Used other than bottled water
(missing data = 3) b
25 (5) 8 3 5 0.144 6 5 0.499 3 4 8 6 0.373 0 5 7 0.336 5 11 5 0.379d
Ate uncooked meat/fish
(missing data = 4)
58 (13) 9 16 18 0.045* 11 14 0.446 6 17 13 6 0.016* 4 12 18 0.080 13 13 11 0.961d
Ate salads (missing data = 26) 341 (79) 77 78 85 0.427 79 78 0.904 59 83 81 74 0.009* 69 78 83 0.288 80 70 78 0.404
Diet (missing data = 159) 0.087 0.018* 0.010* 0.288 1.000d
omnivore 274 (91) 92 88 100 96 88 100 85 92 97 100 92 88 91 91 93
vegetarian 27 (9) 8 12 0 4 12 0 15 8 3 0 8 13 9 9 7
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Table 4 Traveler profiles presented by demographics (destination, sex, age, duration of travel, purpose of travel) with travel behavior in bivariable analysis for 460 travelers.
Results are given in percentages with the largest group shown in bold (Continued)
Used milk as part of diet
(missing data = 161)
293 (98) 99 97 96 0.226d 99 97 0.426d 96 98 99 97 0.599d 100 99 96 0.347d 98 100 100 1.000d
Site of meals
(missing data = 12) b
<0.001* 0.099 <0.001* 0.660 0.042*
restaurant more than 50 % 372 (83) 70 96 87 87 81 53 86 86 83 89 83 81 84 83 68
own household and
sometimes elsewhere
76 (17) 30 4 13 13 19 47 14 14 17 11 17 19 16 17 32
Alcohol consumption
(missing data = 67) c
0.112 <0.001* 0.001* 0.117 0.025*
0–2 units per day 281 (61) 72 74 59 61 78 100 70 64 71 65 69 80 70 64 91
3– units per day 112 (24) 28 26 41 39 22 0 30 36 29 35 31 20 30 36 9
Did not always use utensils
(missing data = 23)
126 (29) 28 34 18 0.070 28 29 0.877 39 40 24 10 <0.001* 17 22 55 <0.001* 26 39 49 0.004*
Did not wash hands
always/often (missing data = 13)
61 (14) 10 16 18 0.147 17 12 0.138 9 21 9 7 0.001* 11 13 17 0.573 14 14 11 0.840
No WC as a toilet
(missing data = 7)
74 (16) 22 13 5 0.004* 17 16 0.747 16 19 18 10 0.235 0 16 21 0.037* 16 14 24 0.411
Had fresh water contact
(missing data = 160)
109 (36) 27 47 28 0.001* 38 35 0.584 26 50 33 14 <0.001* 6 31 59 <0.001* 37 24 46 0.243
Walking barefoot often/
sometimes (missing data = 7)
322 (71) 64 80 69 0.002* 74 69 0.326 88 79 68 55 <0.001* 65 70 77 0.359 74 59 55 0.015*
Unprotected sex with local
(missing data = 27)
8 (2) 4 1 0 0.067d 2 2 1.000d 0 1 4 1 0.239d 0 2 3 0.632d 2 0 3 0.587d
Other close contact with local
(kissing / sharing meals)
(missing data = 26)
82 (19) 23 17 9 0.055 17 20 0.336 18 25 19 8 0.007* 8 15 36 <0.001* 17 24 33 0.039*
Had insect stings
(missing data = 22)
335 (76) 75 81 67 0.058 75 77 0.657 59 88 75 62 <0.001* 19 77 93 <0.001* 76 65 91 0.032*
a 14 (3 %) reported two or more purposes of travel
b Categorized according to lowest standard
c Missing data for children under 16 years was replaced with 0 alcohol servings per day
d Fisher's exact test used
* P-value less than 0.05
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Table 5 Risk factors of contracting illness while traveling / on arrival among 460 travelers. Values are given for proportions of ill
travelers with a given risk factor, odds ratios with 95 % confidence intervals, and p-values in a bivariable analysis
Contracted
illness a %
Odds ratio (95 %
confidence interval)
p-value
Total (missing data = 1) 79
Sex (missing data = 0)
Male 75 1.0
Female 81 1.5 (1.0–2.4) 0.079*
Age group (missing data = 0) <0.001*
0–17 66 1.0
18–35 89 4.3 (1.9–9.9) 0.001
36–55 73 1.4 (0.6–3.2) 0.380
56– 71 1.3 (0.6–2.8) 0.582
Geographic region (missing data = 0) <0.001*
Europe, Northern America 20 1.0
Latin America and the Caribbean 66 7.7 (1.9–32.0) 0.005
Northern Africa, Western Asia 67 8.0 (1.4–45.8) 0.019
Southern Africa 62 6.4 (1.4–28.4) 0.015
Western Africa, Middle Africa 79 14.9 (3.8–58.5) <0.001
Eastern Africa 84 21.6 (5.4–85.8) <0.001
Eastern Asia, Central Asia 56 5.0 (0.8–31.0) 0.084
South-Eastern Asia 87 26.6 (6.7–106.1) <0.001
Southern Asia 91 41.3 (9.1–188.5) <0.001
Duration of travel, days (missing data = 0) <0.001*
1–7 52 1.0
8–29 77 3.0 (1.4–6.7) 0.006
30–160 94 14.4 (4.7–44.1) <0.001
Purpose of travel (missing data = 1) 0.813
Vacation 78 1.0
Business 82 1.2 (0.5–2.9) 0.636
Other/multiple b 82 1.2 (0.5–2.9) 0.636
Accommodation (missing data = 11) c <0.001*
Hotel 68 1.0
Home of a local 87 3.2 (1.5–6.8) 0.003
Guest house 87 3.1 (1.8–5.2) <0.001
Location (missing data = 22) c
City 71 1.0
Countryside/jungle 83 2.0 (1.3–3.3) 0.003*
Used other than bottled water (missing data = 3) c 76 0.8 (0.3–2.2) 0.710
Ate uncooked meat/fish (missing data = 4) 66 0.4 (0.2–0.8) 0.006*
Ate salads (missing data = 26) 78 0.7 (0.4–1.2) 0.192
Diet (missing data = 159)
Omnivore 82 1.0
Vegetarian 89 1.8 (0.5–6.2) 0.353
Used milk as part of diet (missing data = 161) 83 1.0 (0.1–8.5) 1.000e
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Table 5 Risk factors of contracting illness while traveling / on arrival among 460 travelers. Values are given for proportions of ill
travelers with a given risk factor, odds ratios with 95 % confidence intervals, and p-values in a bivariable analysis (Continued)
Site of meals (missing data = 12) c
Restaurant more than 50 % of meals 79 1.0
Own household and sometimes elsewhere 79 1.0 (0.5–1.8) 0.996
Alcohol consumption (missing data = 67) d
0–2 units per day 81 1.0
3– units per day 74 0.7 (0.4–1.1) 0.102
Did not always use utensils (missing data = 23) 85 1.7 (1.0–3.0) 0.058*
Did not wash hands always/often (missing data = 13) 72 0.6 (0.3–1.2) 0.138
No WC as a toilet (missing data = 7) 85 1.6 (0.8–3.2) 0.159
Had fresh water contact (missing data = 160) 84 1.7 (0.9–3.1) 0.109
Walking barefoot often/sometimes (missing data = 7) 79 1.0 (0.6–1.7) 0.990
Unprotected sex with local (missing data = 27) 100 1.0 (1.0–1.0) 0.213e
Other close contact with local (missing data = 26) 88 2.2 (1.1–4.4) 0.030*
Had insect stings (missing data = 22) 84 3.1 (1.9–5.1) <0.001*
a Symptoms started abroad or on return
b 14 (3 %) reported two or more purposes of travel
c Categorized according to lowest standard
d Missing data for children under 16 years was replaced with 0 alcohol servings per day
e Fisher's exact test used
* Factors with P-value <0.1 chosen to multivariable model
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tion, skin problems, and TD.
Discussion
Introduction
Investigations addressing travelers’ health have generally
been retrospective and/or conducted on those seeking
medical care after their journeys, whereas prospective
studies are scarce. Furthermore, research tends to focus
on the effects that one or just a few specific factors have
on travelers’ behavior and illness: destination [4, 26, 27],
length of journey [4, 5, 26, 27], purpose of travel [27],
gender [4, 5, 26, 27], age [4, 5, 26, 27], risk behavior [5],
and particular diseases, such as TD [34–41]. We are not
aware of any earlier investigations into all these factors
with a single prospective cohort of travelers; only one
[4] provides data on the same subjects during and after
travel, and at follow-up.
Morbidity during travel and on return
A central finding of our work is high morbidity rate.
Despite efficient prophylactic measures taken before
travel – exemplified by our vaccination data – the
amount of health problems proved striking: as many as
76 % of our subjects reported illness while abroad, and
25 % still had ongoing symptoms or new complaints
within two days after returning home. The overall pro-
portion of our subjects with any symptoms while
overseas (76 %) correspond to that reported for American
(64 %; [4]), U.K. (64 %; [25]), and Israeli travelers (70 %;[5]), but proved higher than percentages presented for
German (10-43 %; [26, 27]), Swiss (38 %; [24]), and
Swedish travelers (49 %; [23]). As all these investigations
are based on questionnaires, the format of the various
questions concerning symptoms may account for the
differences.
As regards morbidity in different geographic regions,
the percentage of illness proved, as expected, signifi-
cantly smaller for travelers to advanced countries (20 %)
than those visiting developing regions (81 %); the rates
were highest for visitors to Southern Asia, South-
Eastern Asia, and Eastern Africa. TD accounted for the
majority of health problems while abroad / after return
(69 %). This result accords with several previous studies
[4–6, 8, 10, 21–24, 26, 27, 42–44].Morbidity at follow-up
While the symptoms of illness mostly set in abroad, the
figures proved unexpectedly high also during the follow-
up: new health problems were reported by 32 % of our
subjects. This percentage slightly exceeds the result of the
only previous study exploring illness on return and at
follow-up; the morbidity rate reported by Hill is 26 % [4].
The duration of follow-up may account for the small dif-
ference. In our study it was somewhat shorter (three
weeks vs two months). But since the subjects were not
asked to give exact dates for their symptoms, the onset
could afterwards not be limited to 14 days in cases of TD,
respiratory illness, and skin disorders, like in Hill’s report.
Table 6 Risk factors of contracting illness while traveling / on return in the final multivariable model after backward selection of
factors by Akaike information criteriaa. Variables with p-value less than 0.10 in bivariable analysis were chosen to multivariable model.
Values are given for proportions with a given risk factor, adjusted odds ratios with 95 % confidence intervals, and p-values in
multivariable analysis
Proportion of those contracting AOR (95 % CI) for contracting illness among
illness among travelers with travelers with the given risk factor in multivariable
the given risk factor (%) analysis with multiple imputations c p-value
Gender
male 75 1.00
female 81 1.73 (1.03–2.91) 0.040*
Age, years b N/A 1.06 (0.994–1.14) 0.076
Age, quadratic term b N/A 0.999 (0.998–1.00) 0.018*
Geographic region N/A
Europe, Northern America 20 1.00
Latin America and the Caribbean 66 7.90 (1.66–37.6) 0.009*
Northern Africa, Western Asia 67 11.9 (1.82–78.0) 0.010*
Southern Africa 62 9.72 (1.85–51.2) 0.007*
Western Africa, Middle Africa 79 15.5 (3.50–68.7) <0.001*
Eastern Africa 84 18.5 (4.08–83.8) <0.001*
Eastern Asia, Central Asia 56 6.41 (0.930–44.2) 0.059
South-Eastern Asia 87 21.2 (4.48–100) <0.001*
Southern Asia 91 32.4 (6.24–168) <0.001*
Duration of travel, days b N/A 1.025 (1.00–1.05) 0.048*
Accommodation N/A
hotel 68 1.00
home of a local 87 2.36 (0.922–6.06) 0.073
guest house 87 1.78 (0.940–3.36) 0.077
Eating uncooked meat/fish
did not eat uncooked meat/fish 81 1.00
ate uncooked meat/fish 66 0.303 (0.147–0.625) 0.001*
Abbreviations: AOR adjusted odds ratios, CI confidence interval, N/A not applicable
aBackward selection eliminated the following factors: location, other close contact with local, having insect stings, and use of utensils
bAnalyzed as continuous variables. Age also on quadratic term, which seems to be better than age only in the model by AIC
c10 datasets used in imputation
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skin problems, respiratory illness, and TD, a finding ac-
cording with Hill’s results [4]. In our study, fever was the
most frequent single symptom – often associated with
TD. Diarrhea remained the most common cause for
seeking health care.
Profiles
The data revealed regional differences which enabled
profiling our subjects: travelers to Africa tended to be
older and more cautious than those visiting Asia,
whereas visitors to Asia were typically younger and fa-
vored longer trips. Likewise, the data show differences
between travelers by age: the young traveled for longest
and stayed in guest houses more frequently than the
others, were the most likely to eat uncooked meat/fishand salads, not to use utensils, to follow a vegetarian
diet, to neglect hand washing, and not to avoid fresh-
water contact. Not surprisingly, the longer the stay
overseas, the lower the degree of travelers’ compliance
with hygiene instructions. Such traveler profiles can be
used as a tool to target advice at various groups accord-
ing to their special characteristics.
Risk factors
Destination, gender, age, and duration of travel were
shown by multivariable analysis to be factors predisposing
to illness. Southern Asia proved the riskiest resort, as also
reported in earlier studies [4, 26]. Female travelers proved
to be at greater risk of acquiring symptoms (OR 1.7), a
finding according with the results published by Hill [4]. In
the present data, each day increased the risk of
Fig. 2 Demographics and illnesses of the 460 travelers. Each box presents data from one of the nine destinations by reporting the number of
visitors, their median age in years, median duration of travel in days, and percentages of traveler with diarrhea (TD), respiratory tract infection
(RTI), fever, or any symptom while traveling / on arrival. Map graphics devised by Helena Schmidt, HumanArt. N/A = not applicable.1 Europe and
Northern America. 2 Latin America and the Caribbean. 3 Western Africa and Middle Africa. 4 Northern Africa and Western Asia. 5 Southern Africa.
6 Eastern Africa. 7 Southern Asia. 8 South-Eastern Asia. 9 Eastern Asia and Central Asia
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by Hill was 3.1–3.7 % [4]. Young age has often been re-
ported to be associated with illness [4, 5, 8, 23, 26,
27]; in our cohort the risk was highest at 31.5 years.
Eating raw meat or fish proved to be a protective fac-
tor. The reasons for this are not obvious and can
only be speculated on.
Limitations of the study
The present investigation has some limitations which
deserve to be discussed. Firstly, the results are not repre-
sentative of all travelers, but of volunteers with pre-
travel appointments at a travel clinic. Thus visitors to
Africa and other developing regions were overrepre-
sented. Secondly, due to small sample size, statistical
analyses of some subgroups were poorly powered. The
third limitation concerns the follow-up: the reliability of
the conclusions suffers from the fact that only 51 % of
our volunteers completed the questionnaire, and many
delivered it later than requested. Importantly, however,
even if it could be assumed that none of the remaining
49 % had been ill, the number of newly onset symptoms
during follow-up remains substantial. The data would
have benefited from a comparison to non-travelingcontrols. Our data collection can also be regarded as a
limitation, for questionnaire-based studies may distort
the results in various ways. Due to the common use of
questionnaires, this tends to be characteristic of research
into travelers’ health problems [3, 4, 6, 22–27, 42, 44–
48]; a few previous reports include data collected by
telephone surveys [2, 4, 5, 8, 27]. In our study, travel
diaries may have improved the accuracy of data to some
degree. The exact number of clients declining to partici-
pate was not recorded. However, based on the number
of clients seen by the recruiting doctor and number of
those recruited, we estimate that at the maximum 10 %
of the potentially eligible clients declined.
Our data in relation to previous estimates of travelers’
health problems
We recently reported incidences of illness and injury among
more than 50 000 Finnish travelers visiting various regions
[21] by relating cases recorded by an assistance organization
to numbers of travelers to each region. The results were
considered to cover the most severe cases. The present data
complete that picture by showing even the mildest
symptoms contracted. This puts the two studies into per-
spective. Since 90 % of our travelers did not contact health
Table 7 Symptoms and contacts to health care providers. Data are provided for 459 travelers as numbers and percentages
separately for the period during travel, on return, and one month after it
During journey, N Ongoing or started on arrival, N Newly onset during follow-up, N
N/459 (%a) N/453 (%a) N/233 (%a)
Any symptom 351 (76) 113 (25) 74 (32)
travelers' diarrhea 312 (68) 78 (17) 5 (2)
skin problem b 78 (17) 2 (0) 9 (4)
fever >37,5 °C 74 (16) 6 (1) 20 (9)
vomiting 55 (12) 2 (0) 1 (0)
respiratory tract infection 26 (6) 17 (4) 9 (4)
urinary tract infection 17 (4) 1 (0) 4 (2)
ear infection 5 (1) 4 (1) 1 (0)
other gastrointestinal symptoms 19 (4) 2 (0) 4 (2)
other symptoms 16 (3) 6 (1) 40 (17)
Contacts to health care 47 (10) 1 (0) 50 (21)
Outpatient contact with health care c 44 (10) 1 (0) 46 (20)
travelers’ diarrhea 20 (4) 0 (0) 16 (7)
skin problem d 9 (2) 0 (0) 5 (2)
respiratory tract infection 8 (2) 0 (0) 5 (2)
ear infection 4 (1) 0 (0) 1 (0)
malaria / suspected malaria 3 (1) 0 (0) 0 (0)
musculosceletal problem 2 (0) 0 (0) 6 (3)
urinary tract infection 2 (0) 0 (0) 2 (1)
other reason 3 (1) 1 (0) 11 (5)
Inpatient (hospitalization) 3 (1) 0 (0) 4 (2)
travelers’ diarrhea 2 (0) 0 (0) 1 (0)
fever >37,5 °C 0 (0) 0 (0) 1 (0)
respiratory tract infection 0 (0) 0 (0) 1 (0)
suspected malaria 0 (0) 0 (0) 1 (0)
other reason 1 (0) 0 (0) 0 (0)
a Proportion of positive among those from whom information was available
b Dry skin / atopy / acne / insect stings excluded, sunburn / sun rash / infected skin due to insect stings included
c Five travelers reported two or more causes of visit
d Including travelers seeing a doctor because of any skin problem (e.g. insect stings, allergic reactions)
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not amount to more than 10 % of the illness altogether –
slightly less than estimated in that study [21]. The strengths
of the present research include the prospective study design
and the fact that we combined data of three time points
(pre-travel, travel/return, and follow-up) for a single cohort.
Interestingly, the rate of health problems per region
presented in our study accords with risk estimates presented
by International SOS (Additional file 2: Figure S2).
Aspects related to malaria prophylaxis and treatment
Advice on malaria prophylaxis is a cornerstone of pre-
travel appointments. In our data, 289 of the 296 travelers
(98 %) taking malaria prophylaxis reported compliance.
Interestingly, however, four of them, all diagnosed inAfrica, were also treated for malaria while abroad. One case
was microbiologically verified, two reported a negative
malaria test, and one had taken medication without labora-
tory diagnostics. Our earlier data collected by the assistance
organization shows malaria to be rare in travelers (8/50000
cases; Siikamäki, personal communication). Indeed, the
diagnoses of our cases may not be correct, as presumptive
treatment is often given in Africa [49], and malaria diagnos-
tics may not always be accurate [50].
Conclusions
This study with most of its subjects visiting (sub)trop-
ical regions shows that, despite efficient preventive
measures like vaccinations, malaria prophylaxis, and
travel advice, the majority fall ill during or after
Vilkman et al. BMC Infectious Diseases  (2016) 16:328 Page 13 of 14travel. TD is the most common disease while abroad,
followed by skin problems and fever. After travel, the
most frequent complaints are fever, respiratory tract
infections, and skin problems. Symptoms generally
remain mild, not requiring medical care. The propor-
tion of newly onset illness among returning travelers
is considerable: one-third get health problems after
their journeys. Advice regarding this should be given
already at pre-travel appointments.
Additional files
Additional file 1: Figure S1. HealthMap 2010 by International SOS.
Medical risk ratings are based on the standard of local medical and
dental care, access to prescription drugs, the possible prevalence of
serious infectious diseases, and known cultural, linguistic and
administrative barriers. Map printed with the written permission of
International SOS. This map has been developed for illustrative purposes
only. It is a global illustration of medical risk for travellers. For detailed
information, please refer to the country guides at internationalsos.com
© International SOS, 2010. All rights reserved. Unauthorized copy or
distribution prohibited. (PDF 3143 kb)
Additional file 2: Figure S2. HealthMap 2010 by International SOS
presented together with demographics and illnesses of our 460
travelers. Each box presents data from one of the nine destinations by
reporting the number of visitors, their median age in years, median
duration of travel in days, and percentages of traveler with diarrhea
(TD), respiratory tract infection (RTI), fever, or any symptom while
traveling / on arrival. Map printed and modified with the written
permission of International SOS. This map has been developed for
illustrative purposes only. It is a global illustration of medical risk for
travellers. For detailed information, please refer to the country guides
at internationalsos.com © International SOS, 2010. All rights reserved.
Unauthorized copy or distribution prohibited. 1 Europe and Northern
America. 2 Latin America and the Caribbean. 3 Western Africa and
Middle Africa. 4 Northern Africa and Western Asia. 5 Southern Africa. 6
Eastern Africa. 7 Southern Asia. 8 South-Eastern Asia. 9 Eastern Asia
and Central Asia. (TIF 604 kb)
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